Conference Call with Dr. Agarwals Health Care Ltd. Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Dr. Agarwals Health Care announced Q3FY25 results Revenue: Increased by 29.5% YoY, reaching Rs 430.7 crore compared to Rs 332.7 crore in Q3FY24. Other Income stood at Rs 12.7 crore in Q3FY25. EBITDA stood at Rs 118.9 crore in Q3FY25, a 26.3% increase from Rs 101.0 crore in Q3FY24. EBITDA margin was at 27.8% in Q3FY25, compared to 27.7% in Q3FY24. PBT stood at Rs 41.0 crore for Q3FY25, growing by 13.8% compared to Rs 36.0 crore in Q3FY24. PAT increased by 25.0%, reaching Rs 28.2 crore in Q3FY25 from Rs 22.6 crore in Q3FY24. Amar Agarwal, Chairman, said: " February 4, 2025, marked a remarkable achievement in our journey, with the successful listing of our company a testament to the dedication of our team and the trust of our patients.This milestone reinforces our commitment to delivering world-class eye care and advancing the field of vision health. We are also committed to driving research and embracing the latest technological advancements to offer the best possible treatments for all our patients. Furthermore, we aim to empower communities by increasing awareness of eye health, ensuring that eye care becomes accessible to everyone, no matter where they live. This is just the beginning, and together, we will continue to shine a brighter light on the future of eye care." Result PDF